PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
These metrics indicate whether the stock trades cheaply or expensively relative to its fundamentals. Value investors use them to find mispricings—buying stocks that appear undervalued, with solid long-term prospects and limited downside risk.
-2593.20
Negative P/E while Healthcare median is -2.70. Seth Klarman would scrutinize path to profitability versus peers.
No Data
No Data available this quarter, please select a different quarter.
573.65
P/B exceeding 1.5x Healthcare median of 3.30. Jim Chanos would check for potential asset write-down risks.
-1048.75
Negative FCF while Healthcare median P/FCF is -16.36. Seth Klarman would investigate cash flow improvement potential.
-1048.75
Negative operating cash flow while Healthcare median P/OCF is -8.99. Seth Klarman would investigate operational improvement potential.
573.65
Fair value ratio exceeding 1.5x Healthcare median of 3.30. Jim Chanos would check for valuation bubble risks.
-0.01%
Negative earnings while Healthcare median yield is -0.30%. Seth Klarman would investigate path to profitability.
-0.10%
Negative FCF while Healthcare median yield is -0.33%. Seth Klarman would investigate cash flow improvement potential.